"Bioidentical hormones" is one of the most misunderstood terms in women's health. Marketed as safer, more natural, and individualized — the label by itself describes only one thing: that the hormone molecule matches the structure of a hormone your body produces. It says nothing about whether the product is FDA-regulated, evidence-based, or right for you.
What the term actually defines
Bioidentical refers strictly to molecular structure. Estradiol (E2), estrone (E1), estriol (E3), micronized progesterone, and testosterone — when manufactured to match the chemical structure of your body's own hormones — are bioidentical. By contrast, conjugated equine estrogens (Premarin, derived from pregnant mare urine) and synthetic progestins (medroxyprogesterone acetate in Prempro) are not structurally identical to human hormones.
FDA-approved bioidentical products
Most prescription HRT in 2026 is already bioidentical. Estradiol patches (Climara, Vivelle-Dot), gels (Divigel, EstroGel), sprays (Evamist), oral tablets (Estrace), and vaginal preparations (Vagifem, Estrace cream) all contain bioidentical estradiol. Prometrium contains micronized bioidentical progesterone. These products went through standard FDA approval pathways — randomized trials, manufacturing oversight, post-market surveillance — and their bioidentical status is incidental to their safety profile.
Compounded bioidentical hormone therapy (cBHT)
When marketing materials say "bioidentical," they often specifically mean compounded products — custom-mixed by a 503A pharmacy under individual prescription. Compounded bioidentical hormones (cBHT) typically include estradiol, estriol, progesterone, testosterone, and DHEA in customized doses and combinations. Because they are compounded rather than manufactured under FDA approval, they are NOT FDA-approved drugs, even though the molecules they contain are identical to FDA-approved versions.
The American College of Obstetricians and Gynecologists (ACOG), the North American Menopause Society (NAMS), and the Endocrine Society all formally recommend FDA-approved bioidentical hormones over cBHT for most women. The main concerns: dose variability between batches (one study found compounded estradiol creams varied 60% to 270% of labeled dose), lack of post-market surveillance, and marketing claims about "individualized" hormone testing that are not evidence-based.
When cBHT is appropriate
There are legitimate clinical indications for cBHT: documented allergy to a non-active ingredient in an FDA-approved product, need for a dose not commercially available (rare), or a specific delivery form not otherwise marketed. These are narrow indications. For most perimenopausal and postmenopausal women, an FDA-approved bioidentical product is the better choice on safety, predictability, and evidence grounds.
How to read a prescription
If your prescription names a brand (Estrace, Climara, Prometrium, Vivelle-Dot), it's FDA-approved. If it names a compounding pharmacy or specifies a custom formulation (BiEst, TriEst, custom progesterone cream), it's compounded. Both can be bioidentical. The relevant question is not "is it bioidentical?" but "is it FDA-approved, and does my insurance cover it?"
Informational only — your clinician will help you choose between FDA-approved and compounded products based on your situation.